14 NOBEL BIOCARE ANNUAL REPORT <strong>2003</strong>C&B&I BRAND STRUCTUREdemands from dentists and patientsfor ultimate simplicity and esthetics.Two customer groups– two brandsThe segmentation of the implantoffering is based on target groups.Brånemark System reaches out toexperienced implant users, whileReplace is the prime alternative fornew users.Brånemark System has the widestclinical documentation in the market.It is also the world’s most versatileimplant offering, covering all customerneeds for advanced reconstruction.Replace has for many years beenthe fastest growing brand on themarket. As it is easy to use, Replaceisthe obvious choice for easy, efficientand esthetic treatment. Thesecharacteristics make Replace thefirst-choice alternative for generalpractitioners.The main product for new users isReplace Select Tapered. The implantwas the first tapered implant on themarket and to date over one millionimplants have been installed. ReplaceSelect Straight addresses generalpractitioners with some experience ofimplant treatment. It combines thebest-documented features of BrånemarkSystem implant design andReplace internal connection.A common esthetic offer<strong>Nobel</strong> Esthetics is a common prostheticoffer for Brånemark System andReplace, characterized by excellentesthetical results and simplicity. Theconcept means that the dentist doesnot need to know whether thespecialist has installed BrånemarkSystem or Replace. What is visiblelooks exactly the same.Thanks to its unique Procera technology,<strong>Nobel</strong> <strong>Biocare</strong> is the onlycompany in the implant businessoffering both standard abutmentsand individually produced solutions.BrånemarkSystem ®High-end users/SpecialistsMajor product launchesIn <strong>2003</strong> and early 2004, <strong>Nobel</strong> <strong>Biocare</strong>launched two dental implant conceptsthat pushed the borders for estheticsand simplification several steps forward,taking implant treatment as closeto traditional dentistry as it can get.<strong>Nobel</strong>Perfect is the first implantdesigned to replicate natural anatomy.The revolutionary scalloped profilesupports the interproximal boneridge and preserves natural soft tissuecontours between the implant andthe surrounding teeth, avoiding“black triangles” between the teeth.Through the development of a newconcept, including the one-pieceimplant, <strong>Nobel</strong>Direct, launched inearly 2004, <strong>Nobel</strong> <strong>Biocare</strong> is takingdental implants to the point ofultimate simplicity and tissue friendliness.<strong>Nobel</strong>Direct is a new conceptbased on flapless surgery and softtissuehealing with TiUnite. It is aone-stage implant using flapless,minimal-invasive surgery that facilitateshandling and make procedureseasier. Apart from bringing implantseven closer to traditional crown andbridge therapy, <strong>Nobel</strong>Direct and theopportunity of flapless surgery bringsmany advantages to the patient,including minimized discomfort andreduced treatment time.<strong>Nobel</strong> <strong>Biocare</strong> has received clearancefrom the FDA for <strong>Nobel</strong>Direct withseveral different diameters, including<strong>Nobel</strong> Replace ®Procera ®<strong>Nobel</strong> Esthetics <strong>Nobel</strong> <strong>Biocare</strong> New users/General dentistsC&B&I BRAND PROMISES<strong>Nobel</strong> <strong>Biocare</strong> BrånemarkSystem ®Replace ®Procera ®<strong>Nobel</strong>Perfect <strong>Nobel</strong>Direct The world leader in innovativeesthetic dental solutionsThe most versatile and mostclinically proven original so youcan treat virtually every caseThe obvious choice for easy,efficient and esthetic treatmentThe ultimate in personalizedesthetics and efficiencyOptimal esthetics in implanttreatmentPatient friendly, flaplessprocedure, Immediate Functionand Soft Tissue attachmentthe 3 mm implant, which is thethinnest implant for permanentplacement ever approved by the FDA.The 3 mm implant is suitable wherelack of space is a clinical problem.The primary customer target groupsfor <strong>Nobel</strong>Direct are general dentistsand implantologists.The continuous integration of theProcera technology also resulted in thelaunch of a new customized abutment,Procera Abutments Zirconia, for areasdemanding particular strength. As aresult of the launch, <strong>Nobel</strong> <strong>Biocare</strong>’sprosthetic offering for implant treatmentis complete, encompassing bothstandard products and customizedprosthetics in a range of materials fordifferent areas of the mouth.Laboratories
IPMIntellectual PropertyManagement<strong>Nobel</strong> <strong>Biocare</strong>'s product portfoliois state of the art. The increasedcomplexity is a constant challenge forIP management and IP protection.Thus <strong>Nobel</strong> <strong>Biocare</strong> works in this areaworldwide in order to optimize anycombination of the legal and businessaspects of Intellectual PropertyManagement.To obtain optimal protection for itsproducts and services and to reinforcethe company’s brands and marketposition, <strong>Nobel</strong> <strong>Biocare</strong> takes a globaland structured approach to the development,use and protection of IntellectualProperty Management (IPM).The knowledge-intense nature ofthe business and the continued focuson providing complete estheticaldental solutions for its customers meanthat IPM is an important issue for<strong>Nobel</strong> <strong>Biocare</strong>.◗ Trademarks<strong>Nobel</strong> <strong>Biocare</strong> uses the “core brands”<strong>Nobel</strong> <strong>Biocare</strong>, Brånemark System,Replace and Procera to develop andenhance its branding and positioningstrategy.In addition, <strong>Nobel</strong> <strong>Biocare</strong> furtherstrengthens these “core brands” byusing “product brands”, such as therecently launched products <strong>Nobel</strong>-Perfect, <strong>Nobel</strong>Direct and ProceraPiccolo.<strong>Nobel</strong> <strong>Biocare</strong> also uses differenttrademarks in launches and to introduceconcepts, such as C&B&I andImmediate Function.◗ Trade dress or designsSeveral of <strong>Nobel</strong> <strong>Biocare</strong>'s productsare unique, not only from the angleof technical use but also in designaspects. This legal means of protectionhas been enhanced in the US and EUand is used by <strong>Nobel</strong> <strong>Biocare</strong> for theprotection of designs.◗ Patents<strong>Nobel</strong> <strong>Biocare</strong> carefully monitorshow to make the optimal use of patentapplicationsand patent protection.<strong>Nobel</strong> <strong>Biocare</strong> is always at theforefront when it comes to developingnew products and concepts. In <strong>2003</strong>,<strong>Nobel</strong> <strong>Biocare</strong> applied for 17 newpatents.◗ CopyrightMany of <strong>Nobel</strong> <strong>Biocare</strong>’s printedmaterials are protected by copyrightlegislation, as is <strong>Nobel</strong> <strong>Biocare</strong>Procera software.◗ Trade secrets<strong>Nobel</strong> <strong>Biocare</strong> acknowledges that iton a daily basis handles confidentialinformation and know-how that issensitive and proprietary. <strong>Nobel</strong> <strong>Biocare</strong>focuses on informing employees,suppliers and others of the sensitivenature of much of the daily work andprocesses at <strong>Nobel</strong> <strong>Biocare</strong>. We alsoput in place rules and guidelines, aswell as mandatory processes, tomake sure information only reachesthose who should have this specificinformation.NOBEL BIOCARE ANNUAL REPORT <strong>2003</strong>Our trademarks15CORE BRANDS<strong>Nobel</strong> <strong>Biocare</strong> Brånemark System ®Replace ®Procera ®PRODUCT BRANDSNOBELPERFECT NOBELDIRECT Procera ® PiccoloCONCEPTSC&B&I Immediate Function Soft Tissue Integration Dental Implant PatentsGranted US Patents 2001-<strong>2003</strong>* (Number)35302520151050<strong>Nobel</strong><strong>Biocare</strong>Biomet/3iDentsply/FriadentAstraStraumann/ITI* Dental Implant Class A61C 8/00 Espacenet Patent Data baseZimmerDental